| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/29/1997 | WO1997019097A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | WO1997019092A1 Improved process for the synthesis of oligomeric compounds |
| 05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018837A1 Novel non-pyrogenic bacterial strains and use of the same |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018834A1 Therapeutic fragments of von willebrand factor |
| 05/29/1997 | WO1997018829A1 Cartilage/bone inducing materials for reparation |
| 05/29/1997 | WO1997018826A1 Fine tuned protegrins |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018703A1 Method for constructing transgenic animals |
| 05/29/1997 | WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 05/29/1997 | WO1997006247A3 Deubiquitinating enzymes that regulate cell growth |
| 05/29/1997 | WO1997004748A3 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2646500A1 Improved microbial production of indigo |
| 05/29/1997 | CA2646494A1 Improved microbial production of indigo |
| 05/29/1997 | CA2646490A1 Improved microbial production of indigo |
| 05/29/1997 | CA2238610A1 Fine tuned protegrins |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2236825A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | CA2236162A1 Epithelial membrane protein-1 |
| 05/29/1997 | CA2236155A1 Assay for blood clotting factors viii and ix |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/29/1997 | CA2210016A1 Trypsin inhibitor protein from pentaclethra macroloba having insecticidal properties |
| 05/28/1997 | EP0775751A2 Cell transfection |
| 05/28/1997 | EP0775750A2 Preparation of proteins from pro-proteins by fusion proteins derived from furin or furinanalogs |
| 05/28/1997 | EP0775749A1 Subtilisin mutants |
| 05/28/1997 | EP0775748A2 Preparation of D-alpha-amino acids, using bacteria transformed with the carbamoylase-hydantoinase operon |
| 05/28/1997 | EP0775747A2 Genes of the hop latent virus and methods for detecting the same |
| 05/28/1997 | EP0775746A2 Coccidiosis poultry vaccine |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775744A2 Use of boron to regulate genetic transposition |
| 05/28/1997 | EP0775711A1 Peptide having antithrombotic activity and process for producing the same |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775212A2 Control of plant gene expression |
| 05/28/1997 | EP0775211A1 Fumonisin detoxification enzymes |
| 05/28/1997 | EP0775210A1 Mutated penicillin g acylase genes |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775208A2 Insect viruses, sequences, insecticidal compositions and methods of use |
| 05/28/1997 | EP0775207A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 05/28/1997 | EP0775204A1 Antitumor antisense oligonucleotides |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775201A2 An improved cleaning composition |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775198A1 Molecular presenting system |
| 05/28/1997 | EP0775153A1 Nucleic acid to initiate the activity of ribonuclease h or reverse transcriptase |
| 05/28/1997 | EP0775150A1 Endotoxin reduction or removal process |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0774959A1 A liposomal delivery system for biologically active agents |
| 05/28/1997 | EP0774902A1 Antisense and triplex therapeutic agents and methods |
| 05/28/1997 | EP0690921B1 Production of glycolate oxidase in methylotrophic yeast |
| 05/28/1997 | EP0679184A4 Periplasmic 3':5'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same. |
| 05/28/1997 | EP0674734B1 Ski slope maintenance device |
| 05/28/1997 | EP0653064A4 Clinical test for detection of alzheimer's disease. |
| 05/28/1997 | EP0612352B1 Diagnostic applications of double d-loop formation |
| 05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 05/28/1997 | EP0546092B1 Therapeutic ribozyme compositions |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | EP0403554B1 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
| 05/28/1997 | DE19623203A1 Virusvektor für den Transfer stabiler Episome Virus vector for the transfer of stable episomes |
| 05/28/1997 | DE19543628A1 Humanes, im Blut zirkulierendes Peptid mit insulinotroper Wirkung (GCAP-II-(89-112), (Guanylyl Cyclase C Aktivierendes Peptid II) und seine GCAP-Analoga, insbesondere das GCAP-I-(99-115), seine Anwendung als pharmakologischer Wirkstoff und Benutzung seines Wirkungsprinzipes zur Bereitstellung neuer GC-C-abhängiger insulinotroper Wirkstoffe Human, circulating in the blood insulinotropic peptide effect (GCAP-II (89-112), (guanylyl cyclase-activating peptide C II) and its GCAP analogues, in particular the GCAP-I (99-115), its use as a pharmacological drug use and its effect principle to provide new GC-C-dependent insulinotropic drugs |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | CN1150824A A fungus wherein areA gene has been modified and areA gene from aspergillus oryzae |
| 05/28/1997 | CN1150823A A new cephalosporin C acylase |
| 05/28/1997 | CN1150822A Process for producing cis-3-hydroxy-L-proline |
| 05/28/1997 | CN1150821A Process for producing trans-4-hydroxy-L-proline |
| 05/28/1997 | CN1150820A Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 05/28/1997 | CN1150819A Vaccine against mumps containing jeryl-Lynn virus strain |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150602A Human thymosin alpha-source and preparing method thereof |
| 05/28/1997 | CN1150601A Bacteriocin |
| 05/27/1997 | US5633451 Having significant thermal hysteresis activity |
| 05/27/1997 | US5633450 Transformed plant resistant to cold damage, containing dna sequence encoding for chitinase activity |
| 05/27/1997 | US5633449 A dna molecule |
| 05/27/1997 | US5633448 For conferring to plants an increased tolerance to glyphosate |
| 05/27/1997 | US5633447 Plant tissue comprising a subgenomic promoter |
| 05/27/1997 | US5633446 Modified Bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
| 05/27/1997 | US5633444 A genetically engineered plant cell |
| 05/27/1997 | US5633442 Method of producing pathogen-resistant plants |
| 05/27/1997 | US5633441 Genetic engineering |
| 05/27/1997 | US5633440 P119 promoters and their uses |
| 05/27/1997 | US5633439 Expression of genes in transgenic plants using a cinnamyl alcohol dehydrogenase gene promoter |
| 05/27/1997 | US5633438 Isolated dna molecule |
| 05/27/1997 | US5633437 Gene exhibiting resistance to acetolactate synthase inhibitor herbicides |
| 05/27/1997 | US5633436 Chimeric gene which causes increase in total seed methionine in plant cells expressing gene |
| 05/27/1997 | US5633435 For selectively controlling weeds in a planted transgenic crop field |
| 05/27/1997 | US5633434 Transgenic plants displaying virus and phosphinothricin resistance |
| 05/27/1997 | US5633425 Transgenic non-human animals capable of producing heterologous antibodies |